CD4 and neoplasm: PD-L1 is also involved in the maintenance and induction of tumor-associated Tregs by inhibiting the Akt/mTOR signaling cascade, which promotes differentiation and switch from naive CD4+ TL to induced CD4+ CD25+ FOXP3+ Tregs (59, 62, 68, 79).